MAPT and Alzheimer disease: Nevertheless, cerebrospinal fluid (CSF) levels of Aβ42, t-tau (total tau), and p-tau (tau phosphorylated at threonine 181) are considered core biomarkers to support AD diagnosis [6,7,8].